{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:59:10Z","timestamp":1790827150605,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100025496","name":"Dramatists Guild Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AI171491"],"award-info":[{"award-number":["1R21AI171491"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI63594"],"award-info":[{"award-number":["U01 AI63594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AI170424"],"award-info":[{"award-number":["U01 AI170424"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK125823"],"award-info":[{"award-number":["R01DK125823"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK113586"],"award-info":[{"award-number":["R01DK113586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK138960"],"award-info":[{"award-number":["R01DK138960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK076690"],"award-info":[{"award-number":["R01DK076690"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ajt.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:17:34Z","timestamp":1749237454000},"page":"2173-2181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6024-0562","authenticated-orcid":false,"given":"Vojtech","family":"Petr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4139-1979","authenticated-orcid":false,"given":"Filip","family":"Tichanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4035-4185","authenticated-orcid":false,"given":"Samuel L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-8078","authenticated-orcid":false,"given":"Felix","family":"Poppelaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5460-3282","authenticated-orcid":false,"given":"Brandon","family":"Renner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5069-3982","authenticated-orcid":false,"given":"Jennifer","family":"Laskowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1239-3895","authenticated-orcid":false,"given":"Shrey","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7956-2409","authenticated-orcid":false,"given":"Ming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1975-8650","authenticated-orcid":false,"given":"Diana","family":"Jalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-6913","authenticated-orcid":false,"given":"Peter S.","family":"Heeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3476-9956","authenticated-orcid":false,"given":"Joshua M.","family":"Thurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajt.2025.06.003_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1600-6143.2008.02519.x","article-title":"Identifying specific causes of kidney allograft loss","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.06.003_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/ndt\/gfn667","article-title":"Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis","volume":"24","author":"Yarlagadda","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.ajt.2025.06.003_bib3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/00007890-199704150-00011","article-title":"Delayed graft function: risk factors and implications for renal allograft survival","volume":"63","author":"Ojo","year":"1997","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.ajt.2025.06.003_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.170.3.1517","article-title":"Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice","volume":"170","author":"Thurman","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.ajt.2025.06.003_bib5","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI8621","article-title":"Predominant role for C5b-9 in renal ischemia\/reperfusion injury","volume":"105","author":"Zhou","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1523-1755.2005.67109.x","article-title":"Acute tubular necrosis is characterized by activation of the alternative pathway of complement","volume":"67","author":"Thurman","year":"2005","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.ajt.2025.06.003_bib7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2215\/CJN.02200312","article-title":"Clinical analysis of perioperative complement activity during ischemia\/reperfusion injury following renal transplantation","volume":"7","author":"B\u0142ogowski","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ajt.2025.06.003_bib8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2147\/JIR.S334738","article-title":"Tumor necrosis factor-\u03b1 gene polymorphism is associated with short- and long-term kidney allograft outcomes","volume":"15","author":"Poppelaars","year":"2022","journal-title":"J Inflamm Res"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ki.2014.285","article-title":"TNF receptors: signaling pathways and contribution to renal dysfunction","volume":"87","author":"Al-Lamki","year":"2015","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ajt.2025.06.003_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1096\/fj.05-3841com","article-title":"TNFR1- and TNFR2-mediated signaling pathways in human kidney are cell type-specific and differentially contribute to renal injury","volume":"19","author":"Al-Lamki","year":"2005","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.ajt.2025.06.003_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14728222.2019.1586886","article-title":"Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target","volume":"23","author":"Medler","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.ajt.2025.06.003_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-6143.2009.02921.x","article-title":"Role of TNF\u03b1 in early chemokine production and leukocyte infiltration into heart allografts","volume":"10","author":"Ishii","year":"2010","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.ajt.2025.06.003_bib13","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.06.003_bib14","doi-asserted-by":"crossref","unstructured":"Hricik D, Armstrong B, Alhamad T, et al. Infliximab induction lacks efficacy and increases BK virus infection in deceased donor kidney transplant recipients: Results of the CTOT-19 Trial. J Am Soc Nephrol2023;34(1):145-159. https:\/\/doi.org\/10.1681\/ASN.2022040454.","DOI":"10.1681\/ASN.2022040454"},{"issue":"1","key":"10.1016\/j.ajt.2025.06.003_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/TP.0000000000004736","article-title":"Tacrolimus after rATG and infliximab induction immunosuppression\u2014RIMINI trial","volume":"108","author":"Viklicky","year":"2024","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.ajt.2025.06.003_bib16","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210518","article-title":"Ferroptosis in infection, inflammation, and immunity","volume":"218","author":"Chen","year":"2021","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.ajt.2025.06.003_bib17","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri.2016.63","article-title":"Innate sensing of oxidation-specific epitopes in health and disease","volume":"16","author":"Binder","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.ajt.2025.06.003_bib18","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2796.2008.01968.x","article-title":"Oxidation-specific epitopes are important targets of innate immunity","volume":"263","author":"Chou","year":"2008","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ Res"},{"issue":"52","key":"10.1016\/j.ajt.2025.06.003_bib20","doi-asserted-by":"crossref","first-page":"13798","DOI":"10.1073\/pnas.1714027115","article-title":"Early endosome as a pathogenic target for antiphosphatidylethanolamine antibodies","volume":"114","author":"Hou","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ajt.2025.06.003_bib21","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/JLB.3RI0519-161R","article-title":"Secreted IgM: new tricks for an old molecule","volume":"106","author":"Blandino","year":"2019","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.ajt.2025.06.003_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fimmu.2016.00198","article-title":"Role of natural autoantibodies and natural IgM anti-leucocyte autoantibodies in health and disease","volume":"7","author":"Lobo","year":"2016","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ajt.2025.06.003_bib23","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.4049\/jimmunol.180.3.1780","article-title":"Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis","volume":"180","author":"Lobo","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2025.06.003_bib24","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/ajt.16404","article-title":"A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury","volume":"21","author":"Li","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ajt.2025.06.003_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0065-2776(04)86004-8","article-title":"Innate autoimmunity","volume":"86","author":"Carroll","year":"2005","journal-title":"Adv Immunol"},{"issue":"6","key":"10.1016\/j.ajt.2025.06.003_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1681\/ASN.2004060447","article-title":"Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease","volume":"16","author":"Poggio","year":"2005","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10263","key":"10.1016\/j.ajt.2025.06.003_bib28","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(20)32411-9","article-title":"Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial","volume":"396","author":"Jochmans","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ajt.2025.06.003_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43353","article-title":"Donor time to death and kidney transplant outcomes in the setting of a 3-hour minimum wait policy","volume":"7","author":"Tingle","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ajt.2025.06.003_bib30","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nprot.2008.48","article-title":"A protocol for determination of anticardiolipin antibodies by ELISA","volume":"3","author":"Pierangeli","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.ajt.2025.06.003_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2016.10.005","article-title":"The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine","volume":"440","author":"Hou","year":"2017","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.ajt.2025.06.003_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"brms: an R package for Bayesian multilevel models using Stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J Stat Softw"},{"issue":"6","key":"10.1016\/j.ajt.2025.06.003_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1681\/ASN.2017111157","article-title":"Post-transplant natural antibodies associate with kidney allograft injury and reduced long-term survival","volume":"29","author":"See","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.ajt.2025.06.003_bib34","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/TP.0000000000004472","article-title":"Natural antibodies are associated with rejection and long-term renal allograft loss in a multicenter international cohort","volume":"107","author":"See","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.ajt.2025.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7005080","article-title":"Natural antibodies and alloreactive T cells long after kidney transplantation","volume":"2021","author":"Van Besouw","year":"2021","journal-title":"J Transplant"},{"issue":"10","key":"10.1016\/j.ajt.2025.06.003_bib36","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1097\/01.TP.0000438626.91095.50","article-title":"Oxidative stress in kidney transplantation: malondialdehyde is an early predictive marker of graft dysfunction","volume":"97","author":"Fonseca","year":"2014","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.ajt.2025.06.003_bib37","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/00007890-199805270-00007","article-title":"Oxidative stress and lipid abnormalities in renal transplant recipients with or without chronic rejection","volume":"65","author":"Cristol","year":"1998","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.ajt.2025.06.003_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ndt\/gfx353","article-title":"Anticardiolipin antibodies and 12-month graft function in kidney transplant recipients: a prognosis cohort survey","volume":"33","author":"Gauthier","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.ajt.2025.06.003_bib39","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1755.2003.00155.x","article-title":"Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients","volume":"64","author":"Ducloux","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00007890-199907270-00014","article-title":"Antiphospholipid antibodies are a risk factor for early renal allograft failure","volume":"68","author":"Wagenknecht","year":"1999","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.ajt.2025.06.003_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/IAI.67.2.595-601.1999","article-title":"Tumor necrosis factor alpha receptor I is important for survival from Streptococcus pneumoniae infections","volume":"67","author":"O\u2019Brien","year":"1999","journal-title":"Infect Immun"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613525002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:33:26Z","timestamp":1790825606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613525002953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1600613525002953"],"URL":"https:\/\/doi.org\/10.1016\/j.ajt.2025.06.003","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajt.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}